The attenuating effect of CBD on MCAM, VE-cadherin, and Endoglin expression and its capacity to increase CD34+ ECs could therefore be a contributory factor in the anti-angiogenic anti-tumor effect described for CBD, while also increasing CD34+ endothelial progenitor cell-mediated repair. This evidence concerns the gene CD34 and neoplasm.